Navigation Links
OncoGenex Announces Completion Of Patient Enrollment In Custirsen Phase 3 "SYNERGY" Study
Date:11/6/2012

BOTHELL, Wash. and VANCOUVER, British Columbia, Nov. 6, 2012 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today the completion of patient enrollment in the primary registration Phase 3 study, known as SYNERGY, evaluating custirsen in patients with advanced prostate cancer.

The SYNERGY study is designed to evaluate a survival benefit for custirsen, when added to first-line chemotherapy, in men with metastatic castrate-resistant prostate cancer (mCRPC). The SYNERGY study is the first of two, ongoing, pivotal Phase 3 studies evaluating a potential survival benefit for custirsen treatment in prostate cancer. 

Over 1000 men have been enrolled to the SYNERGY study, at 142 sites primarily in North America and Europe. The survival primary endpoint data are event-driven and results are expected by the end of 2013.

"Completing enrollment of SYNERGY is an exciting and important milestone for the custirsen development program and for our company," said Scott Cormack, President and CEO of OncoGenex Pharmaceuticals. "We are one step closer to our goal of truly understanding the clinical benefit of custirsen in a large, randomized Phase 3 study, and to bringing forward a new treatment that could potentially extend the lives of men with prostate cancer."

The SYNERGY trial was initiated based on results of the OncoGenex Phase 2 trial in patients with metastatic CRPC receiving custirsen in combination with first-line docetaxel chemotherapy. These patients experienced a 6.9 month improvement in overall survival in comparison with those patients who received docetaxel alone.

Custirsen has received Fast Track designation from the FDA for the treatment of progressive metastatic prostate cancer in combination with docetaxel. The FDA has also agreed on the design of the SYNERGY trial through the special protocol assessment (SPA) p
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AMRI Announces Third Quarter 2012 Results
2. Egenix, Inc. Announces New Director
3. BioRestorative Therapies Announces Stock Trading On OTC Bulletin Board
4. WebMD Announces Third Quarter Financial Results
5. Life Technologies Announces Third Quarter 2012 Results
6. HealthTech Capital Announces Awards for the HealthTech Conference 2012 - Building a Business in the New HealthTech Ecosystem
7. Omeros Announces Enrollment in Phase 1 Clinical Trial Evaluating OMS824
8. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
9. IntelliCell BioSciences Announces Myron Z. Holubiak Joins the IntelliCell BioSciences Board of Directors
10. Synthetic Biologics Announces $10.8 Million Financing
11. Haemonetics Reports Second Quarter Fiscal 2013 Revenue Up 22%, Organic Revenue Up 6% and Adjusted EPS of $0.90, Reaffirms Fiscal 2013 Guidance and Announces Two-For-One Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... (PRWEB) November 21, 2014 Two new educational ... what comes next for ALS research and how the pharmaceutical ... After the Ice Bucket Challenge: Where Does the ALS Money ... Tuesday, 2 December 2014, Time: 1:30pm ET, Register ... expert speaker Dr. Merit Cudkowicz, Julianne Dorn Professor of Neurology ...
(Date:11/22/2014)... (PRWEB) November 21, 2014 During his ... understood the need to surround himself with great people ... and entrepreneur, his friends often marveled at his extraordinarily ... lived his life and -- even with his death ... the Alzheimer’s disease that would ultimately take his life. ...
(Date:11/22/2014)... (PRWEB) November 21, 2014 Prominent ... investors will gather on December 3rd at Genetic ... Conferences series. GeneticRx will take place at the ... School and will discuss the present and future ... exon skipping, and gene editing—as well as the ...
(Date:11/22/2014)... CannLabs, Inc. (OTCQB: CANL), the leading ... methodologies relating to cannabis, today announced that it has ... from an existing stockholder of the Company. , ... from one of our existing stockholders,” stated Mark ... help accelerate our planned expansions into the Connecticut and ...
Breaking Biology Technology:DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 3Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2CannLabs Secures $750,000 Line Of Credit 2
... media attention focused on the effects of outsourcing technology ... on the issue. Whatever the product, there is an ... The effects of this are hurting many aspects of ... you are making, whether you manufacture low- to high-tech ...
... Health System is reducing surgery delays and controlling instrument ... surgical instruments and trays by using a new surgical ... Software. , ,Gundersen Lutheran operates a teaching hospital ... largest group medical practices, community clinics, eye clinics and ...
... Paul Voss looks at the future in terms of ... reveal upcoming trends in the technology needed by certain ... sociology from the University of Wisconsin-Madison addressed the Madison ... presentation titled Americas Changing Demographic Portrait. He said the ...
Cached Biology Technology:Offshore outsourcing affects American workers 2Offshore outsourcing affects American workers 3Gunderson Lutheran Implements Instrument Management Systems 2Using Demographic Predictions, UW Prof Expounds Upon Trends in Tech 2
(Date:11/21/2014)... According to a new market ... RFID, Access Control, Intrusion Detection, Parking Management, Under Vehicle ... Service Geography - Global Forecasts to 2020", published by ... be around $25 Billion in 2014 and is expected ... CAGR of 8.69%. Browse 116 market data ...
(Date:11/21/2014)... -- Earlier this year Donald Spector , Chairman of ... the most prolific inventors in the world, got a ... to third party agencies. Spector envisioned this technology even ... earliest known patents in this area. Now major technology ... care, elder care and hospital applications. This technology has ...
(Date:11/21/2014)... , Nov. 20, 2014 Strict laws ... efficiency are piloting the North American and European automotive ... accidents growing, gesture recognition systems that are intuitive and ... mark in the industry. New analysis ... Gesture Recognition Market in Europe ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4
... therapy has been identified by Monash University scientists investigating ... involved in cancer development. , A team led by ... has identified two proteins that are involved in stopping ... is essential if cancer cells are to proliferate. , ...
... the Nov. 24 issue of Science provide further support for ... new evidence that adult precursor cells from the spleen can ... and 2003, researchers at Massachusetts General Hospital (MGH) demonstrated the ... in diabetic mice. Three studies from other institutions published ...
... dolphin drive hunts begin in the Japanese villages of Taiji ... aquarium professionals has launched a campaign to end the practices ... Japan to put an end to the hunts. The "Act ... Emory University, and the World Association of Zoos and Aquariums ...
Cached Biology News:New target for cancer therapy identified 2New data from NIH lab confirms protocol to reverse type 1 diabetes in mice 2Renewed dolphin slaughter prompts new campaign 2Renewed dolphin slaughter prompts new campaign 3
PA coated Agarose beads LPA Beads...
... This protein is a member of ... factors. Members of the PAX family typically ... paired-type homeodomain. These proteins play critical roles ... gene 3 are associated with Waardenburg syndrome, ...
Anti-Human alpha2-Antiplasmin Purified (Polyclonal) (goat IgG)...
Anti (porcine) Vitronectin...
Biology Products: